OBJECTIVE: To characterize the expression and function of interleukin (IL) 19, a recently described T-helper 2 anti-inflammatory IL, on endothelial cell (EC) pathophysiological features. METHODS AND RESULTS: The expression and effects of anti-inflammatory ILs on EC activation and development of angiogenesis are uncharacterized. We demonstrate by immunohistochemistry and immunoblot that IL-19 is expressed in inflamed, but not normal, human coronary endothelium and can be induced in cultured human ECs by serum and basic fibroblast growth factor. IL-19 is mitogenic and chemotactic, and it promotes EC spreading. IL-19 activates the signaling proteins STAT3, p44/42, and Rac1. In functional ex vivo studies, IL-19 promotes cordlike structure formation of cultured ECs and enhances microvessel sprouting in the mouse aortic ring assay. IL-19 induces tube formation in gelatinous protein (Matrigel) plugs in vivo. CONCLUSIONS: To our knowledge, these data are the first to report expression of the anti-inflammatory agent, IL-19, in ECs; and the first to indicate that IL-19 is mitogenic and chemotactic for ECs and can induce the angiogenic potential of ECs.
OBJECTIVE: To characterize the expression and function of interleukin (IL) 19, a recently described T-helper 2 anti-inflammatory IL, on endothelial cell (EC) pathophysiological features. METHODS AND RESULTS: The expression and effects of anti-inflammatory ILs on EC activation and development of angiogenesis are uncharacterized. We demonstrate by immunohistochemistry and immunoblot that IL-19 is expressed in inflamed, but not normal, human coronary endothelium and can be induced in cultured human ECs by serum and basic fibroblast growth factor. IL-19 is mitogenic and chemotactic, and it promotes EC spreading. IL-19 activates the signaling proteins STAT3, p44/42, and Rac1. In functional ex vivo studies, IL-19 promotes cordlike structure formation of cultured ECs and enhances microvessel sprouting in the mouse aortic ring assay. IL-19 induces tube formation in gelatinous protein (Matrigel) plugs in vivo. CONCLUSIONS: To our knowledge, these data are the first to report expression of the anti-inflammatory agent, IL-19, in ECs; and the first to indicate that IL-19 is mitogenic and chemotactic for ECs and can induce the angiogenic potential of ECs.
Authors: Haluk B Oral; Sergei V Kotenko; Mustafa Yilmaz; Orlando Mani; Judith Zumkehr; Kurt Blaser; Cezmi A Akdis; Mübeccel Akdis Journal: Eur J Immunol Date: 2006-02 Impact factor: 5.532
Authors: D B Cines; E S Pollak; C A Buck; J Loscalzo; G A Zimmerman; R P McEver; J S Pober; T M Wick; B A Konkle; B S Schwartz; E S Barnathan; K R McCrae; B A Hug; A M Schmidt; D M Stern Journal: Blood Date: 1998-05-15 Impact factor: 22.113
Authors: William J Jordan; Joyce Eskdale; Michele Boniotto; Greig P Lennon; Jon Peat; John D M Campbell; Grant Gallagher Journal: Eur J Immunol Date: 2005-05 Impact factor: 5.532
Authors: Christian S Haas; M Asif Amin; Brittany B Allen; Jeffrey H Ruth; G Kenneth Haines; James M Woods; Alisa E Koch Journal: Arthritis Rheum Date: 2006-08
Authors: Farah Kako; Khatuna Gabunia; Mitali Ray; Sheri E Kelemen; Ross N England; Bashar Kako; Rosario G Scalia; Michael V Autieri Journal: Am J Physiol Cell Physiol Date: 2016-04-06 Impact factor: 4.249
Authors: Stephen Ellison; Khatuna Gabunia; Sheri E Kelemen; Ross N England; Rosario Scalia; James M Richards; A Wayne Orr; Wayne Orr; James G Traylor; Thomas Rogers; William Cornwell; Lisa M Berglund; Isabel Goncalves; Maria F Gomez; Michael V Autieri Journal: Arterioscler Thromb Vasc Biol Date: 2013-08-15 Impact factor: 8.311
Authors: James Richards; Khatuna Gabunia; Sheri E Kelemen; Farah Kako; Eric T Choi; Michael V Autieri Journal: J Mol Cell Cardiol Date: 2014-11-08 Impact factor: 5.000
Authors: Khatuna Gabunia; Stephen P Ellison; Harrinder Singh; Prasun Datta; Sheri E Kelemen; Victor Rizzo; Michael V Autieri Journal: J Biol Chem Date: 2011-12-12 Impact factor: 5.157